What Goes into Valuing a hospital: Key Factors
Financial Health: This is the foundation. We look at how much money the hospital makes (revenue growth), how profitable it is (EBITDA margins), its cash flow, and the return it provides on investments. Effective hospital revenue management, along with steady income, good cost management, and strong profits, generally makes a hospital worth more.
Operational strength: Efficiency matters. Factors like how many beds are occupied, how much revenue each occupied bed generates (ARPOB), patient numbers, and the smooth operation of clinical and administrative processes all play a role. Better efficiency usually means a higher valuation.
Quality Clinical Leadership & Ownership: The presence of highly skilled medical professionals, particularly when they have an ownership interest, provides stability and confidence, positively impacting the hospital’s value
Quality of Facilities and Services: The condition of the hospital buildings, the modernity of its medical equipment, and the technology it uses are important. Hospitals offering advanced and specialized treatments that attract more patients and can charge premium prices tend to be valued higher.
Market Standing: A hospital’s share of the local market, its brand reputation, and its position compared to other healthcare providers in the area are crucial. Hospitals with a strong local presence and brand often get better valuations.
Following the Rules: The healthcare industry is heavily regulated. Hospitals that consistently comply with regulations, have important accreditations (like NABH), and have a clean record are more valuable. Any regulatory problems can lower their worth.
Potential for Growth: Investors are interested in the future. Hospitals with plans to expand, introduce new services, or reach new patient groups are seen as more valuable.
Strategic Location & Catchment Area: A hospital’s geographic placement and the demographics of its surrounding patient population are crucial for accessibility, patient volume, and ultimately, its valuation.
Reputation and Trust: A hospital’s good name, the loyalty of its patients, and the trust people have in its medical staff are valuable assets that contribute to its overall worth.
Why Some Hospitals Get Higher Valuations:
Focus on Profitable Specialties: Hospitals specializing in high-demand and high-margin areas like heart care, cancer treatment, brain surgery, and fertility often command higher prices.
Strong Brand and Trust: Hospitals known for excellent medical care and positive patient experiences are more valuable.
Good Locations: Hospitals in major cities or areas with a large number of insured patients tend to have better revenue and higher valuations.
Consistent Growth: Hospitals that have shown a steady increase in revenue and profits, with clear plans for future expansion, are attractive to buyers.
Efficient Operations: Well-managed hospitals that use their resources effectively are more profitable and thus more valuable.
Emerging Markets: The growing healthcare awareness and increasing disposable incomes in Tier II and Tier III cities are making hospitals in these locations increasingly attractive to investors, presenting significant growth potential.
Why Some Hospitals Might Have Lower Valuations:
Financial Problems: Hospitals struggling with low patient numbers, high costs, or significant debt are usually valued lower.
Inefficient Operations: Poor management and outdated facilities can negatively impact a hospital’s worth.
Regulatory Issues: A history of not following regulations or facing legal challenges can reduce a hospital’s value.
Strong Competition: Hospitals in areas with many competitors might face pressure on pricing and profitability, leading to lower valuations.
Heavy Reliance on Government Schemes with Low Payments: While treating a large number of patients through government schemes can provide volume, the lower reimbursement rates can affect profitability and overall value.
Examples from FY 2025 and What They Tell Us

General Atlantic’s Investment in Ujala Cygnus: Information suggests General Atlantic invested in Ujala Cygnus at an enterprise value of approximately ₹1600 crore, translating to a valuation of around ₹64 lakhs per bed. This per-bed valuation appears comparatively lower than some other deals witnessed during the year. Ujala Cygnus’s focus on Tier II and Tier III cities, which typically have a lower ARPOB (Average Revenue Per Occupied Bed), likely contributes to this. While the growth potential of these emerging markets attracts investors, the valuation may remain somewhat conservative compared to hospitals in more established urban centers.
KKR’s Acquisition of Majority Stake in HCG: KKR’s acquisition of a majority stake in HealthCare Global Enterprises (HCG) is reported to have been at an attractive valuation. This deal also underscores the strong potential and investor interest in the oncology segment within the Indian healthcare market in the coming years. Similarly, valuation of Omega healthcare also indicates perceived potential of oncology business in India.
Transaction Month | Acquirer | Target | Location | % of stake | Valuation in Cr | Valuation per beds | Revenue Multiple | EBIDTA Multiple | Remarks |
---|---|---|---|---|---|---|---|---|---|
Apr-24 | General Atlantic | Ujala Cygnus | Northern India (Tier-II and Tier-III cities) | 70% | 1,600 | 0.64 | 2.78 | 21.33 | Tier II and III cities presence |
Apr-24 | Manipal Hospitals | Medica Synergie | Kolkata | 87% | 1,609 | 1.61 | 2.63 | 13.17 | Strengthens Manipal's presence in eastern India |
Jun-24 | HealthCare Global Enterprises Ltd (HCG) | Mahatma Gandhi Cancer Hospital & Research Institute (MGCHRI) | Visakhapatnam | 51% initially (to increase to 85% in 18 months) | 414 | 2.11 | 3.45 | 9.86 | |
Jun-24 | Morgan Stanley | Omega Hospitals | South India | 23% | 2,100 | 1.50 | FY 24 data is not avaialble. Multiple seems high based FY 23 revenue and EBIDTA | ||
Jul-24 | KKR | Baby Memorial Hospital (BMH) | South India | 70% | 2,500 | 2.50 | 6.08 | 31.03 | |
Jul-24 | MGM Healthcare | Seven Hills Hospital | Visakhapatnam | 100% | 171 | 0.57 | Acquired through the CIRP | ||
Jul-24 | Krishna Institute of Medical Sciences Ltd (KIMS) | Chalasani Hospitals Private Ltd (QNRI) | Visakhapatnam | 100% | 75 | 0.38 | With real estate - Land 1.5 lacs sq ft | ||
Aug-24 | Peerless Group | SKM Hospital | Barasat | 100% | NA | Data not available | |||
Sep-24 | Max Healthcare | Jaypee Hospital life first | Noida, Bulandshahr, Anoopshahr | 64% | 1660 | 2.37 | 3.94 | 23.71 | Acquisition thru debt repayment of Rs. 1000 cr |
Oct-24 | Yatharth Hospital and Trauma Care Services Ltd | MGS Infotech Research and Solutions Private Ltd | Faridabad | 60% | 152 | 0.38 | Expected to be operatoinal in 6-10 mths after acquisition | ||
Oct-24 | Yatharth Hospital | MD City Hospital | Model Town, New Delhi | 100% | 160 | 0.53 | Acquired through SARFAESI Act e-auction | ||
Oct-24 | Manipal Hospitals | Khubchandani Hospital | Andheri, Mumbai | 100% | 415 | 0.83 | Acquisition focus on real estate - 2.6 acre land , 2 lacs + sq ft BU area | ||
Feb-25 | Fortis Healthcare | Shrimann Superspecialty Hospital | Jalandhar, Punjab | 100% | 462 | 2.03 | 3.00 | 12.83 | Revenue and EBiDTA multiple- expected for FY 25 |
Feb-25 | KKR | HCG | Pan India | 54% | 6417 | 2.57 | 3.20 | 18.00 |
How Hospital Values Are Really Determined: Beyond the Numbers
Negotiation:
Synergies:
In Conclusion
Valuing a hospital in India for a merger or acquisition is a complex process. While financial analysis is important, the final value is often shaped by negotiation, looking at value from different angles, and considering the strategic fit and future potential of the hospital. As the Indian healthcare industry continues to grow and consolidate, understanding these factors, along with comprehensive financial planning and analysis services, will be crucial for everyone involved.